Grade 3–5 acneiform rash was more common in the arm with cetuximab (17%) than in the RT alone arm (1%); this difference was statistically highly significant (P = < 0.001).
← all excerpts
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.
1
—
—